Stuglik Brian M plan to sell securities of PUMA BIOTECHNOLOGY, INC. under Form 144

Stuglik Brian M filed Form 144 to notify SEC of plan to sell 8100 units of PUMA BIOTECHNOLOGY, INC. securities around 2026-06-12, with aggregate market value of $58,806.00. The total outstanding units is 50899456.0. The amount planned to be sold represents 0.02% of total outstanding units;